GTR Home > Tests > Search results - GLA[gene]

Apply filters

Showing tests for all 1072 conditions

Compare labs

Your search term can be found in tests with a total of 1072 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

More test methods
  • Hide states
More locations

GTR test search results for 2717[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 94 tests for 1072 conditions in 63 labs

CFabry disease

Lab: Centogene AG - the Rare Disease Company Centogene AG Rostock, Mecklenburg-Vorpommern, Germany
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CGLA (Alpha-Galactosidase A) Gene Testing in Fabry Disease

Lab: GeneDx Gaithersburg, Maryland, United States
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CGLA Sequence Analysis

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CGLA Sequence Analysis (Prenatal Diagnosis)

Conditions
Test targets
Methods
  • T Targeted variant analysis

CGLA Sequence Analysis (Familial Mutation/Variant Analysis)

Conditions
Test targets
Methods
  • T Targeted variant analysis

CGLA Sequence Analysis

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CGLA Comprehensive - Sequence & Deletion/Duplication Analysis

Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CPan Cardiomyopathy Panel (51 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (89)
Total targets (51)

CHCM Panel (18 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (36)
Total targets (18)

CHypertrophic Cardiomyopathy NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (15)

CFabry Disease via the GLA Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHypertrophic cardiomyopathy with suspeced Fabry disease

Lab: Health in Code S.L. A Coruña, Galicia, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNuclearMitome Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (387)
Total targets (434)

CHypertropic Cardiomyopathy Panel_2013

Lab: Health in Code S.L. A Coruña, Galicia, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (53)

CDilated cardiomyopathy Panel_2013

Lab: Health in Code S.L. A Coruña, Galicia, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (75)

CCardiomyopathy Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (12)
Total targets (70)

CGLA - Fabry Disease

Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CGLA. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCardiomyopathy - entire panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (30)

Showing 1 to 20 of 94 tests for 1072 conditions in 63 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk